245 related articles for article (PubMed ID: 1316224)
21. Modulation of differentiation in PA-1 human teratocarcinoma cells after N-ras oncogene-induced tumorigenicity.
Tainsky MA; Yim SO; Krizman DB; Kannan P; Chiao PJ; Mukhopadhyay T; Buettner R
Oncogene; 1991 Sep; 6(9):1575-82. PubMed ID: 1681491
[TBL] [Abstract][Full Text] [Related]
22. Oncogenes and tumor-suppressor genes.
Lehman TA; Reddel R; Peiifer AM; Spillare E; Kaighn ME; Weston A; Gerwin BI; Harris CC
Environ Health Perspect; 1991 Jun; 93():133-44. PubMed ID: 1685442
[TBL] [Abstract][Full Text] [Related]
23. Cytogenetic instability with balanced chromosome changes in an SV40 transformed human uroepithelial cell line.
Meisner LF; Wu SQ; Christian BJ; Reznikoff CA
Cancer Res; 1988 Jun; 48(11):3215-20. PubMed ID: 2835156
[TBL] [Abstract][Full Text] [Related]
24. Reversal of the malignant phenotype by an anti-ras ribozyme.
Kashani-Sabet M; Funato T; Tone T; Jiao L; Wang W; Yoshida E; Kashfinn BI; Shitara T; Wu AM; Moreno JG
Antisense Res Dev; 1992; 2(1):3-15. PubMed ID: 1422085
[TBL] [Abstract][Full Text] [Related]
25. Suppression of tumorigenicity in somatic cell hybrids. II. Human chromosomes implicated as suppressors of tumorigenicity in hybrids with Chinese hamster ovary cells.
Klinger HP; Shows TB
J Natl Cancer Inst; 1983 Sep; 71(3):559-69. PubMed ID: 6577230
[TBL] [Abstract][Full Text] [Related]
26. Lovastatin, a cholesterol biosynthesis inhibitor, inhibits the growth of human H-ras oncogene transformed cells in nude mice.
Sebti SM; Tkalcevic GT; Jani JP
Cancer Commun; 1991 May; 3(5):141-7. PubMed ID: 2043425
[TBL] [Abstract][Full Text] [Related]
27. Karyotypic changes associated with spontaneous acquisition and loss of tumorigenicity in a human transformed bronchial epithelial cell line: evidence for in vivo selection of transformed clones.
Schiller JH; Bittner G; Wu SQ; Meisner L
In Vitro Cell Dev Biol Anim; 1998 Apr; 34(4):283-9. PubMed ID: 9590501
[TBL] [Abstract][Full Text] [Related]
28. Reversion of uroepithelial cell tumorigenesis by the ectopic expression of human wnt-5a.
Olson DJ; Gibo DM; Saggers G; Debinski W; Kumar R
Cell Growth Differ; 1997 Apr; 8(4):417-23. PubMed ID: 9101087
[TBL] [Abstract][Full Text] [Related]
29. Neoplastic transformation and DNA-binding of 4,4'-methylenebis(2-chloroaniline) in SV40-immortalized human uroepithelial cell lines.
Swaminathan S; Frederickson SM; Hatcher JF; Reznikoff CA; Butler MA; Cheever KL; Savage RE
Carcinogenesis; 1996 Apr; 17(4):857-64. PubMed ID: 8625501
[TBL] [Abstract][Full Text] [Related]
30. Suppression of tumorigenicity in hybrids of normal and oncogene-transformed CHEF cells.
Craig RW; Sager R
Proc Natl Acad Sci U S A; 1985 Apr; 82(7):2062-6. PubMed ID: 3856884
[TBL] [Abstract][Full Text] [Related]
31. Recessive (mediator-) revertants from c-H-ras oncogene-transformed NIH 3T3 cells: tumorigenicity in nude mice and transient anchorage and serum independence of the recovered tumor cells in culture.
Omata-Yamada T; Yamada H; Lengyel P
J Cell Physiol; 1991 Nov; 149(2):214-21. PubMed ID: 1748716
[TBL] [Abstract][Full Text] [Related]
32. Identification of a human chromosome 11 gene which is differentially regulated in tumorigenic and nontumorigenic somatic cell hybrids of HeLa cells.
Lichy JH; Modi WS; Seuanez HN; Howley PM
Cell Growth Differ; 1992 Aug; 3(8):541-8. PubMed ID: 1390339
[TBL] [Abstract][Full Text] [Related]
33. Introduction of the ras oncogene transforms a simian virus 40-immortalized hepatocyte cell line without loss of expression of albumin and other liver-specific genes.
Isom HC; Woodworth CD; Meng Y; Kreider J; Miller T; Mengel L
Cancer Res; 1992 Feb; 52(4):940-8. PubMed ID: 1371091
[TBL] [Abstract][Full Text] [Related]
34. Suppression of tumorigenicity in human cell hybrids derived from cell lines expressing different activated ras oncogenes.
Geiser AG; Anderson MJ; Stanbridge EJ
Cancer Res; 1989 Mar; 49(6):1572-7. PubMed ID: 2647289
[TBL] [Abstract][Full Text] [Related]
35. ras-induced neoplastic transformation and sensitivity to tumor necrosis factor.
Fernandez A; Chen PW; Ananthaswamy HN
Anticancer Res; 1994; 14(6B):2649-52. PubMed ID: 7872696
[TBL] [Abstract][Full Text] [Related]
36. Role of chromosome loss in ras/myc-induced Syrian hamster tumors.
Oshimura M; Koi M; Ozawa N; Sugawara O; Lamb PW; Barrett JC
Cancer Res; 1988 Mar; 48(6):1623-32. PubMed ID: 2449958
[TBL] [Abstract][Full Text] [Related]
37. Cooperation between the H-ras oncogene and a truncated derivative of the v-myb oncogene in transformation of hamster embryo fibroblasts.
Merzak A; Dooghe Y; Pironin M; Perbal B; Vigier P
Oncogene; 1992 Oct; 7(10):2031-9. PubMed ID: 1408144
[TBL] [Abstract][Full Text] [Related]
38. Tumorigenicity of simian virus 40-transformed human cells and mouse--human hybrids in nude mice.
Koprowski H; Croce CM
Proc Natl Acad Sci U S A; 1977 Mar; 74(3):1142-6. PubMed ID: 191830
[TBL] [Abstract][Full Text] [Related]
39. Genetic analysis of tumorigenesis. XXXI: Retention of short arm of chromosome 3 in suppressed CHEF cell hybrids containing c-Ha-ras (EJ) gene.
Craig RW; Gadi IK; Sager R
Somat Cell Mol Genet; 1988 Jan; 14(1):41-53. PubMed ID: 3277292
[TBL] [Abstract][Full Text] [Related]
40. Suggestive evidence for functionally distinct, tumor-suppressor genes on chromosomes 1 and 11 for a human fibrosarcoma cell line, HT1080.
Kugoh HM; Hashiba H; Shimizu M; Oshimura M
Oncogene; 1990 Nov; 5(11):1637-44. PubMed ID: 2267132
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
